Morning Call For Tuesday, Dec. 18

Overnight U.S. Stock Movers

Norfolk Southern (NSC -2.19%) was upgraded to 'Overweight' from 'Neutral' at JPMorgan Chase with a price target of $203.

CVS Health (CVS -1.66%) was rated a new 'Overweight' at Barclays with a price target of $91.

Boeing (BA -0.82%) gained more than 1% in after-hours trading after it boosted its share buyback plan by $2 billion to $20 billion from $18 billion and boosted its quarterly dividend to $2.055 per share from $1.71 per share.

Johnson & Johnson (JNJ -2.90%) rose nearly 1% in after-hours trading after it said it will buy back as much as $5 billion of its own stock.

Abbott Laboratories (ABT -1.43%) was rated a new 'Outperform' at Credit Suisse with a price target of $82.

HealthEquity (HQY -3.96%) was upgraded to 'Overweight' from 'Neutral' at Cantor Fitzgerald with a price target of $82.

Edwards Lifesciences (EW -3.19%) was rated a new 'Outperform' at Credit Suisse with a price target of $188.

Oracle (ORCL -1.87%) gained more than 1% in after-hours trading after it reported Q2 adjusted EPS of 80 cents, better than consensus of 78 cents.

EOG Resources (EOG -3.87%) was rated a new 'Buy' at SunTrust Robinson Humphrey with a price target of $130.

Boston Scientific (BSX -4.89%) was rated a new 'Outperform' at Credit Suisse with a price target of $42.

Marathon Oil (MRO -2.13%) was rated a new 'Buy' at SunTrust Robinson Humphrey with a price target of $25.

Puma Biotechnology (PBYI -5.14%) climbed more than 5% in after-hours trading after it reported positive results in its Phase III trial of its Neratinib in patients with metastatic breast cancer.

1 2 3 4
View single page >> |
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.